HomeCompareOMIC vs GBDC

OMIC vs GBDC: Dividend Comparison 2026

OMIC yields 10.00% · GBDC yields 11.86%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GBDC wins by $20.81M in total portfolio value
10 years
OMIC
OMIC
● Live price
10.00%
Share price
$20.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$38.7K
Annual income
$1,873.10
Full OMIC calculator →
GBDC
GBDC
● Live price
11.86%
Share price
$12.65
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.85M
Annual income
$16,450,733.83
Full GBDC calculator →

Portfolio growth — OMIC vs GBDC

📍 GBDC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOMICGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OMIC + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OMIC pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OMIC
Annual income on $10K today (after 15% tax)
$849.58/yr
After 10yr DRIP, annual income (after tax)
$1,592.14/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.91/yr
After 10yr DRIP, annual income (after tax)
$13,983,123.76/yr
At 15% tax rate, GBDC beats the other by $13,981,531.62/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OMIC + GBDC for your $10,000?

OMIC: 50%GBDC: 50%
100% GBDC50/50100% OMIC
Portfolio after 10yr
$10.44M
Annual income
$8,226,303.47/yr
Blended yield
78.76%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

OMIC
Analyst Ratings
2
Buy
2
Hold
1
Sell
Consensus: Buy
Altman Z
-3.3
Piotroski
3/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.7% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OMIC buys
0
GBDC buys
0
No recent congressional trades found for OMIC or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOMICGBDC
Forward yield10.00%11.86%
Annual dividend / share$2.00$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1%
Portfolio after 10y$38.7K$20.85M
Annual income after 10y$1,873.10$16,450,733.83
Total dividends collected$14.3K$20.43M
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusBuyBuy

Year-by-year: OMIC vs GBDC ($10,000, DRIP)

YearOMIC PortfolioOMIC Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$11,700$999.50$12,492$1,791.70$792.00GBDC
2$13,611$1,092.86$16,527$3,160.58$2.9KGBDC
3$15,752$1,188.27$23,588$5,904.90$7.8KGBDC
4$18,140$1,285.22$37,141$11,901.65$19.0KGBDC
5$20,793$1,383.22$66,205$26,463.38$45.4KGBDC
6$23,731$1,481.79$137,452$66,612.65$113.7KGBDC
7$26,972$1,580.48$342,372$195,298.53$315.4KGBDC
8$30,539$1,678.86$1,053,292$686,954.33$1.02MGBDC
9$34,453$1,776.52$4,111,439$2,984,416.95$4.08MGBDC
10$38,738$1,873.10$20,849,974$16,450,733.83$20.81MGBDC

OMIC vs GBDC: Complete Analysis 2026

OMICStock

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company has partnerships with Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics to validate their library preparation kits on the G4, as well as the Broad Institute of MIT and Harvard to connect the G4 to Terra platform, a data platform. Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in La Jolla, California.

Full OMIC Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this OMIC vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OMIC vs SCHDOMIC vs JEPIOMIC vs OOMIC vs KOOMIC vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.